MorphoSys AG (MOR) Sharpe Ratio

The table compares MorphoSys AG's Sharpe Ratio with other stocks in the Biotechnology industry across multiple time periods, showing how MOR's risk-adjusted performance compares to industry peers.

Data shows 1-, 5-, and 10-year periods, plus each stock's all-time average, as of Jun 4, 2026.

The chart shows MOR's rolling Sharpe ratio over time compared to your chosen benchmark. Rising trends indicate improving returns relative to total volatility, while declining trends may signal deteriorating risk-adjusted performance or increased volatility. Use multiple timeframes to distinguish short-term fluctuations from long-term patterns.

Identify market cycles by observing when MOR consistently outperforms (line above benchmark), underperforms (below benchmark), or aligns with the benchmark.